Well done to Dr Ferguson and Dr Ho. Our case ‘Extensive mucocutaneous, oesophageal and otic lichen planus secondary to Nivolumab therapy’ has recently been published in Skin Health and Disease.
Anti-PD-1 therapy is a type of immunotherapy and an area in increasing development for its efficacy and advantages in the treatment of advanced metastatic melanoma.
Lichenoid reactions are well recognised within the context of anti-PD-1 therapy. We report a rare case of lichen planus occurring in the mucous membranes, oesophagus and otic canal. This case highlights the importance of considering systemic involvement in these patients. These cases can be difficult to treat especially within the context of malignancy.
Read more here – https://doi.org/10.1002/ski2.8